Show simple item record

dc.contributor.authorMalerba, Cristina.
dc.date.accessioned2020-12-01T15:07:56Z
dc.date.available2020-12-01T15:07:56Z
dc.date.issued2020-08-01
dc.identifier.citationRev Enferm Neonatal. Agosto 2020;33:34-42.en_US
dc.identifier.issn2591-6424
dc.identifier.urihttps://riu.austral.edu.ar/handle/123456789/1004
dc.description.abstractMeasles is a severe and highly transmissible viral disease, since it develops in more than 90 % of sus- ceptible contacts. It can cause complications such as pneumonia, encephalitis, and death, especially in the most vulnerable populations. The disease is transmit- ted through respiratory dropsthat are removed during coughing, by speaking, or through small aerosolized drops. The fetus whose mother has immunity against measles due to previous disease or vaccination, re- ceives antibodies by the transplacental route, which protect it during the first 6 to 12 months of life. Pre- mature newborns are more vulnerable to infections and respiratory complications. The only treatment is symptomatic and for bacterial complications. Argentina achieved the status of a measles-free country, but from 2018 to mid-2019, an outbreak of the disease took place, probably due to deficits in immunization coverage. It is considered that the most efficient way to stop this outbreak is to vaccinate the entire susceptible population.en_US
dc.description.sponsorshipAcceso Free: https://drive.google.com/file/d/1ajpnSJpD_HgJpH1PrHM9ulkViWnSa6yb/viewen_US
dc.language.isoesen_US
dc.publisherFUNDASAMIN (Fundación para la Salud Materno Infantil)en_US
dc.subjectCongenital measlesen_US
dc.subjectPregnanten_US
dc.subjectNewbornen_US
dc.subjectPreventionen_US
dc.titleBrote de enfermedad inmunoprevenible: el regreso del sarampiónen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record